Market Overview The global hyperlipidemia drug market is experiencing growth driven by cardiovascular disease burden, lipid management importance, and therapeutic advancement enabling risk reduction. The global hyperlipidemia drug market is projected to exceed USD 35 billion through 2030, fueled by hyperlipidemia prevalence, cardiovascular burden, and drug effectiveness. Lipid-lowering drugs...